Pharmacological inhibition of Hpo kinase blocked NF-κB transcriptional program and suppressed ccRCC cell growth, which can be rescued by overexpression of ZHX2 or p65. This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.